There are 3397 resources available
Role of biomarkers / ctDNA monitoring in therapy decisions
Presenter: Aleix Prat
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
It is not just survival: Rehabilitation, quality of life and late toxicities
Presenter: Femke Jansen
Session: How do we best monitor patients during follow-up?
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Genetic predisposition in patients with sarcoma
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Controversies in early stage triple negative breast cancer
Resources:
Slides
Webcast
LBA61 - Durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC: Final analysis from PACIFIC-6
Presenter: Marina Garassino
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Conclusions and perspectives
Presenter: Rebecca Dent
Session: Controversies in early stage triple negative breast cancer
Resources:
Webcast
Discussion
Presenter: All Speakers
Session: How do we best monitor patients during follow-up?
Resources:
Slides
Webcast
1292MO - A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ039A
Presenter: Ryo Ko
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA62 - Durvalumab after radiotherapy (RT) in patients with unresectable stage III NSCLC ineligible for chemotherapy (CT): Primary results from the DUART study
Presenter: Andrea Riccardo Filippi
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1293MO - Safety and efficacy of hypo- and conventionally fractionated thoracic radiotherapy plus durvalumab in elderly or frail NSCLC stage III patients unfit for chemotherapy: Interim results from the TRADE-hypo trial
Presenter: Farastuk Bozorgmehr
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast